chr17:7674241:G>A Detail (hg38) (TP53)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr17:7,577,559-7,577,559 View the variant detail on this assembly version. |
hg38 | chr17:7,674,241-7,674,241 |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_000546.5:c.722C>T | NP_000537.3:p.Ser241Phe |
NM_001126112.2:c.722C>T | NP_001119584.1:p.Ser241Phe | |
NM_001276760.1:c.722C>T | NP_001263689.1:p.Ser241Phe |
Summary
MGeND
Clinical significance |
![]() ![]() |
Variant entry | 2 |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
ClinVar
Clinical Significance |
![]() ![]() |
Review star | ![]() |
Show details |
Disease area statistics
MGeND
Clinical significance | Last evaluated | Condition | Origin | Submission ID | Submitter | Institute | Citation | Comment | Image |
---|---|---|---|---|---|---|---|---|---|
![]() |
2018/04/12 | Gall bladder cancer |
![]() |
MGS000017
(TMGS000052) |
Kohei Miyazono | Tokyo University | |||
![]() |
li-fraumeni syndrome |
![]() |
MGS000001
(TMGS000174) |
Kenjiro Kosaki | Keio University |
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
1993-01-01 | no assertion criteria provided | hepatoblastoma |
![]() |
Detail |
![]() |
1993-01-01 | no assertion criteria provided | bone osteosarcoma |
![]() |
Detail |
![]() ![]() |
2022-06-18 | criteria provided, multiple submitters, no conflicts | Hereditary cancer-predisposing syndrome |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided |
![]() |
Detail | |
![]() |
2016-05-31 | no assertion criteria provided | non-Hodgkin lymphoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided |
![]() |
Detail | |
![]() |
2016-05-31 | no assertion criteria provided | Carcinoma of esophagus |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Breast neoplasm |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Squamous cell carcinoma of the head and neck |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | uterine carcinosarcoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | lung adenocarcinoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Malignant melanoma of skin |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Papillary renal cell carcinoma, sporadic |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Neoplasm of brain |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | glioblastoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Malignant neoplasm of body of uterus |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided |
![]() |
Detail | |
![]() |
2016-05-31 | no assertion criteria provided | Neoplasm of the large intestine |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | pancreatic adenocarcinoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | ovarian serous cystadenocarcinoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | gallbladder carcinoma |
![]() |
Detail |
![]() |
2016-05-31 | no assertion criteria provided | Papillary renal cell carcinoma type 1 |
![]() |
Detail |
![]() |
2023-12-17 | criteria provided, single submitter | Li-Fraumeni syndrome |
![]() |
Detail |
![]() |
2018-12-01 | no assertion criteria provided | Neoplasm of ovary |
![]() |
Detail |
![]() |
2019-04-30 | no assertion criteria provided | Lip and oral cavity carcinoma |
![]() |
Detail |
![]() |
2024-02-16 | criteria provided, multiple submitters, no conflicts | Li-Fraumeni syndrome 1 |
![]() ![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-04-22 | criteria provided, single submitter | Basal cell carcinoma, susceptibility to, 7,Bone marrow failure syndrome 5,hepatocellular carcinoma,Glioma susceptibility 1,colorectal cancer,choroid plexus papilloma,Li-Fraumeni syndrome 1,Adrenocortical carcinoma, hereditary,bone osteosarcoma,Familial cancer of breast,Nasopharyngeal carcinoma,Carcinoma of pancreas |
![]() |
Detail |
![]() |
2022-09-09 | criteria provided, multiple submitters, no conflicts | not provided |
![]() ![]() |
Detail |
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.441 | Li-Fraumeni syndrome 1 | The consensus coding sequences of human breast and colorectal cancers. | UNIPROT | 16959974 | Detail |
0.441 | Li-Fraumeni syndrome 1 | NA | CLINVAR | Detail | |
0.122 | Neoplastic Syndromes, Hereditary | NA | CLINVAR | Detail | |
0.382 | osteosarcoma | NA | CLINVAR | Detail | |
0.130 | hepatoblastoma | NA | CLINVAR | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Hepatoblastoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Bone osteosarcoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Hereditary cancer-predisposing syndrome | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Squamous cell carcinoma of the skin | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Non-Hodgkin lymphoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Brainstem glioma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Carcinoma of esophagus | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Breast neoplasm | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Squamous cell carcinoma of the head and neck | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Uterine carcinosarcoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Lung adenocarcinoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Malignant melanoma of skin | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Papillary renal cell carcinoma, sporadic | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Neoplasm of brain | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Glioblastoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Malignant neoplasm of body of uterus | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Transitional cell carcinoma of the bladder | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Neoplasm of the large intestine | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Pancreatic adenocarcinoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Ovarian serous cystadenocarcinoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Gallbladder carcinoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Papillary renal cell carcinoma type 1 | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Li-Fraumeni syndrome | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Neoplasm of ovary | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Lip and oral cavity carcinoma | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND Li-Fraumeni syndrome 1 | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND multiple conditions | ClinVar | Detail |
NM_000546.6(TP53):c.722C>T (p.Ser241Phe) AND not provided | ClinVar | Detail |
The consensus coding sequences of human breast and colorectal cancers. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs28934573 dbSNP
- Genome
- hg38
- Position
- chr17:7,674,241-7,674,241
- Variant Type
- snv
- Reference Allele
- G
- Alternative Allele
- A
Genome browser